Pseudoephedrine Hydrochloride

盐酸伪麻黄碱

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NamePseudoephedrine Hydrochloride
Drug Alias Namepseudoephedrinum盐酸异麻黄碱pseudoefedrinaNexafedSudafed
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor agonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsShy-Drager SyndromeMultiple System AtrophyRhinitis, Allergic +[5] 
Global Approved IndicationsRhinitis, AllergicNasal Obstruction
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMcneil Products Ltd
Inactive CompaniesPerrigo Company PlcSanofi-Aventis U.S. LlcVanderbilt University +[4] 
Active IndicationsRhinitis, Allergic
Inactive IndicationsShy-Drager SyndromeMultiple System AtrophyNasal Obstruction +[4] 

Other Information

ATC CodeR01BA02
Related LinksWikipediaDrugBankKEGG